Mapatumumab (HGS-ETR1) is a fully human agonistic monoclonal antibody targeting the TNF-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Mapatumumab exhibits anticancer activity, primarily by inducing tumor cell death through the activation of the death receptor-mediated apoptosis pathway. Mapatumumab is intended for use in cancer research.
Purity:
97.85%
CAS Number:
[658052-09-6]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted